Phase 1 Recurrent Solid Tumors Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Metastatic Solid TumorsLocally Advanced Solid TumorsRecurrent Solid Tumors

Genentech, Inc.250 enrolled18 locationsNCT06031441

Recruiting

Phase 1

EVM16 Injection As a Single and Combination with Tislelizumab in Solid Tumors

Advanced or Recurrent Solid Tumors

Peking University78 enrolled2 locationsNCT06541639